Sphinganine is associated with 24-h MAP in the non-sleepy with OSA.
Victoria M PakKatherine RussellZhenzhen ShiQiang ZhangJohn CoxKaran UppalTianwei YuVicki HertzbergKen LiuOctavian C IoachimescuNancy CollopDonald L BliwiseNancy G KutnerAnn RogersSandra B DunbarPublished in: Metabolomics : Official journal of the Metabolomic Society (2022)
This is the first study to evaluate the relationship of inflammation and oxidative stress related metabolites in sleepy versus non-sleepy participants with newly diagnosed OSA and their association with 24-h MAP. Our study suggests that Sphinganine is associated with 24 hour MAP in the non-sleepy participants with OSA.